Repro Med Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Repro Med Stock Summary

Repro Med competes with Precision Optics,, InfuSystems Holdings, Utah Medical, Milestone Scientific, and Merit Medical. KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Chester, New York. Koru Medical operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 77 people.

Repro Med Key Financial Ratios

Repro Med Key Balance Sheet Accounts

Repro Med Key Income Statement Accounts

Repro Med Key Cash Accounts

Repro Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Repro Med's current stock value. Our valuation model uses many indicators to compare Repro Med value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Repro Med competition to find correlations between indicators driving Repro Med's intrinsic value. More Info.Repro Med Systems is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Repro Med's Return On Equity is projected to slightly decrease based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Repro Med by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Repro Med Systems Systematic Risk

Today, most investors in Repro Med Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Repro Med's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Repro Med growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Repro Med help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Repro Med Systems. We use our internally-developed statistical techniques to arrive at the intrinsic value of Repro Med Systems based on widely used predictive technical indicators. In general, we focus on analyzing Repro Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Repro Med's daily price indicators and compare them against related drivers.

When running Repro Med's price analysis, check to measure Repro Med's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repro Med is operating at the current time. Most of Repro Med's value examination focuses on studying past and present price action to predict the probability of Repro Med's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repro Med's price. Additionally, you may evaluate how the addition of Repro Med to your portfolios can decrease your overall portfolio volatility.